Definium Therapeutics US, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Definium Therapeutics US, Inc.
RECRUITINGPhase 3NCT06809595
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Panorama
Sponsor: Definium Therapeutics US, Inc.Enrolling: 25020 locations
Generalized Anxiety Disorder
RECRUITINGPhase 2NCT07303907
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder
Sponsor: Definium Therapeutics US, Inc.Enrolling: 201 location
Autism Spectrum DisorderASD